Checkmate Pharmaceuticals Statistics Share Statistics Checkmate Pharmaceuticals has 0
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 23.34K, so 0% of the outstanding
shares have been sold short.
Short Interest 23.34K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.01 and the forward
PE ratio is null.
Checkmate Pharmaceuticals's PEG ratio is
0.04.
PE Ratio -1.01 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.89 P/FCF Ratio -1.16 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Checkmate Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.89,
with a Debt / Equity ratio of 0.
Current Ratio 7.89 Quick Ratio 7.89 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.05M Employee Count 30 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Checkmate Pharmaceuticals's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 7.3 200-Day Moving Average n/a Relative Strength Index (RSI) 88.85 Average Volume (20 Days) 233,019
Income Statement
Revenue n/a Gross Profit n/a Operating Income -61.41M Net Income -61.41M EBITDA -61.34M EBIT -61.41M Earnings Per Share (EPS) -2.84
Full Income Statement Balance Sheet The company has 50.67M in cash and 0 in
debt, giving a net cash position of 50.67M.
Cash & Cash Equivalents 50.67M Total Debt n/a Net Cash n/a Retained Earnings -201.48M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -53.72M
and capital expenditures 0, giving a free cash flow of -53.72M.
Operating Cash Flow -53.72M Capital Expenditures n/a Free Cash Flow -53.72M FCF Per Share -2.48
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
